esmolol hydrochloride · Hq Spclt Pharma · NDA 205703
Esmolol Hydrochloride Double Strength In Plastic Container
Earliest generic entry, as listed
15 Mar 2033
Blocked by patent: US 8829054, US 8835505.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8829054 | drug product · sets the listed date | 15 Mar 2033 |
| US 8835505 | drug product · sets the listed date | 15 Mar 2033 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 205703 · 002 · RLD | solution, intravenous | 2GM/100ML (20MG/ML) | 15 Mar 2033 |